Subscribe to Newsletter
Diagnostics Omics, Oncology, Precision medicine

Democratizing Tumor Genomic Profiling With Tailored Content

sponsored by Agilent

Register here

June 26, 2024 - 8am PT

To advance research for precision oncology, it is essential to identify molecular changes that underly tumorigenesis. 

Now you can tailor tumor genomic profiling assays by customizing next-generation sequencing (NGS) cancer panels to fit your laboratory’s specific requirements, including the assessment of new and emerging biomarkers, the immuno-oncology biomarkers (tumor mutational burden (TMB) and microsatellite instability (MSI)), and homologous recombination deficiency (HRD). 

Agilent SureDesign, a user-friendly panel design software powered by machine learning, offers fast and easy design of Agilent SureSelect Cancer Custom panels to enable detection of key classes of somatic alterations. 

In this webinar, you will learn about:

  • The range of available tumor genomic profiling assays (comprehensive, tumor-specific, customized) in the Agilent SureSelect Cancer product portfolio
  • Designing customized cancer panels with SureDesign, by leveraging globally curated, cancer-specific genes and curating your own gene list
  • Achieving high-quality results from samples such as formalin-fixed, paraffin-embedded (FFPE) tissues 
  • Improving lab efficiency by streamlining library preparation and target enrichment with automation, reducing hands-on time to as little as 15 minutes 
  • Integrated workflows incorporating NGS sample and library QC, compatibility across multiple sequencing platforms, and informatics options

Register here

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Automating Hybrid Capture NGS Workflow on AVENIO Edge

| Contributed by Roche

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register